Frederick Thomas E, Namanja Andrew T, Wu Haihong, Sun Chaohong, Petros Andrew M
Research & Development, AbbVie, 1 North Waukegan Road, North Chicago, Illinois 60064, United States.
ACS Med Chem Lett. 2025 Mar 10;16(4):688-692. doi: 10.1021/acsmedchemlett.4c00540. eCollection 2025 Apr 10.
Biophysical confirmation of the binding of small molecules to protein targets plays a critical role in lead discovery campaigns. While protein-detect NMR can provide binding confirmation over a range of affinities, it is especially useful, as opposed to other biophysical methods, for ligands which bind weakly to their protein targets, as is often the case early in the lead discovery process. However, the NMR approach, in its most robust form, requires the isotopic labeling of the protein, thus limiting its overall utility. Here we describe an approach to both confirm small-molecule binding and measure ligand affinities that does not require isotopic labeling of protein targets. This novel method utilizes 1D-diffusion filtered NMR followed by ECHOS analysis and will enable the use of protein-detect NMR to characterize ligand-protein interactions for many protein targets which are currently out of reach.
小分子与蛋白质靶点结合的生物物理确认在先导化合物发现活动中起着关键作用。虽然蛋白质检测核磁共振(NMR)可以在一系列亲和力范围内提供结合确认,但与其他生物物理方法相比,它对于那些与蛋白质靶点弱结合的配体特别有用,而这在先导化合物发现过程的早期经常出现。然而,最强大形式的NMR方法需要对蛋白质进行同位素标记,从而限制了其整体实用性。在这里,我们描述了一种既可以确认小分子结合又可以测量配体亲和力的方法,该方法不需要对蛋白质靶点进行同位素标记。这种新方法利用一维扩散滤波NMR,然后进行ECHOS分析,将能够使用蛋白质检测NMR来表征许多目前无法实现的蛋白质靶点的配体-蛋白质相互作用。